MORPHINE-INDUCED CATALEPSY IS AUGMENTED BY NMDA RECEPTOR ANTAGONISTS,BUT IS PARTIALLY ATTENUATED BY AN AMPA RECEPTOR ANTAGONIST

Citation
Tm. Tzschentke et Wj. Schmidt, MORPHINE-INDUCED CATALEPSY IS AUGMENTED BY NMDA RECEPTOR ANTAGONISTS,BUT IS PARTIALLY ATTENUATED BY AN AMPA RECEPTOR ANTAGONIST, European journal of pharmacology, 295(2-3), 1996, pp. 137-146
Citations number
39
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
295
Issue
2-3
Year of publication
1996
Pages
137 - 146
Database
ISI
SICI code
0014-2999(1996)295:2-3<137:MCIABN>2.0.ZU;2-7
Abstract
High doses of morphine produce a state of behavioural inactivity and m uscular rigidity. This type of 'catalepsy' is clearly different from t he state which is produced by the administration of neuroleptics, e.g. haloperidol. While haloperidol-induced catalepsy can easily be antago nised by NMDA receptor antagonists, there has been a report that the n on-competitive NMDA receptor antagonist 0,11-dihydro-5H-dibenzo[a,d]cy clohepten-5,10-imine (MK-801) potentiates morphine-induced catalepsy. The aim of this study was to further examine the role of glutamate rec eptors in the mediation of morphine-induced catalepsy. To this end we coadministered morphine (20, 40, 60 mg/kg i.p.) with MK-801 (0.1 and 0 .3 mg/kg i.p.), the competitive NMDA receptor antagonist DL-(E)-2-amin o-4-methyl-5-phosphono-3-pentoic acid (CGP 37849) (2 and 6 mg/kg i.p.) , or -4-methyl-7,8-methylen-dioxy-5H-2,3-benzodiazepine (GYKI 52466) ( 2 and 4 mg/kg), an antagonist of the AMPA type of glutamate receptors, respectively. The degree of catalepsy was assessed using two differen t methods, the 'bar/podium/grid' test which is commonly used to measur e neuroleptic-induced catalepsy, and a test for the presence or absenc e of righting reflexes after turning the animals into a supine positio n. It was found that in the 'bar/podium/grid' test coadministration of both NMDA receptor antagonists significantly and dose-dependently aug mented morphine-induced catalepsy. The results using the AMPA receptor antagonist were less clear since the lower dose of GYKI 52466 tended to attenuate the morphine effect whereas the higher dose augmented mor phine-induced catalepsy in some cases. While placing the animals on th e bar and on the podium produced essentially the same results, the gri d was found to be inapplicable for the measurement of morphine-induced catalepsy since the animals did not cling to the grid and fell off al most immediately after being released from the experimenter's hand. Wi th respect to the righting reflexes it was found that the number of an imals not showing these responses increased when MK-801 or CGP 37849 w as coadministered with morphine. In contrast, most of the animals trea ted with GYKI 52466 and morphine displayed intact righting reflexes. I t is concluded that glutamatergic transmission plays an important role in the mediation of morphine-induced catalepsy, though different to t hat of haloperidol-induced catalepsy, and that NMDA and AMPA receptors are differentially involved in different aspects of the associated be havioural state.